U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9009190091Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese EncephalitisCompletedNo Results AvailableJapanese EncephalitisBiological: Mouse brain derived japanese encephalitis vaccine (MB-JEV)|Biological: Primary and booster immunizations with MB-JEV|Biological: C) primary immunizations with Ixiaro|Biological: S) Ixiaro booster to MBJEV primedhttps://ClinicalTrials.gov/show/NCT01386827
9009290092Neuropsychological Sleep Physical Exercise HypoxiaNot yet recruitingNo Results AvailableHypoxiahttps://ClinicalTrials.gov/show/NCT01386814
9009390093Multicenter Research Study to Build a Repository to Study Chronic Diseases in IndianaActive, not recruitingNo Results AvailableDiabetes Mellitus Type IIhttps://ClinicalTrials.gov/show/NCT01386801
9009490094European Survey: Risk of Cyanide Poisoning in Smoke InhalationRecruitingNo Results AvailableSmoke Inhalation PatientsOther: There is no intervention planned (observational)https://ClinicalTrials.gov/show/NCT01386788
9009590095Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial VariationCompletedNo Results AvailableHypohidrotic Ectodermal Dysplasiahttps://ClinicalTrials.gov/show/NCT01386775
9009690096Effect of Intense Multi-modal Training on Bone Health and Quality of Life in Persons With Spinal Cord InjuryRecruitingNo Results AvailableSpinal Cord Injury|ObesityOther: Exercise traininghttps://ClinicalTrials.gov/show/NCT01386762
9009790097Effect of Low-Magnitude, High Frequency Vibration Treatment on Femoral Shaft Fracture HealingCompletedNo Results AvailableFracture, Closed, Comminuted, HealingProcedure: vibration platform provide low magnitude and high frequency vibration treatment, which is self-developed by our research teamhttps://ClinicalTrials.gov/show/NCT01386749
9009890098Vitamin D and Glucose Metabolism in PediatricsRecruitingNo Results AvailableInsulin Resistance|Obesity|Vitamin D25 InsufficiencyDrug: Vitamin D drops|Drug: Placebo dropshttps://ClinicalTrials.gov/show/NCT01386736
9009990099"End of EXTEND: Observing for Cure in Patients With Chronic ITP"RecruitingNo Results AvailablePurpura, Thrombocytopenic, IdiopathicOther: Observational studyhttps://ClinicalTrials.gov/show/NCT01386723
9010090100Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaNot yet recruitingNo Results AvailableGlioblastoma Multiforme|Anaplastic AstrocytomaDrug: Bevacizumab and Carboplatin|Drug: Bevacizumab and Carboplatinhttps://ClinicalTrials.gov/show/NCT01386710
9010190101DIBH Proton PlanningCompletedNo Results AvailableLung Cancer|Breast Cancer|Gastrointestinal|Lymphomatous Malignancieshttps://ClinicalTrials.gov/show/NCT01386697
9010290102Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational StudyActive, not recruitingNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT01386684
9010390103Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesActive, not recruitingNo Results AvailableType 2 DiabetesDrug: Metformin glycinate|Drug: Metformin hydrochloridehttps://ClinicalTrials.gov/show/NCT01386671
9010490104A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary AngioedemaRecruitingNo Results AvailableHereditary AngioedemaDrug: icatibanthttps://ClinicalTrials.gov/show/NCT01386658
9010590105Effect of Dietary Glycemic Index on Beta-cell FunctionRecruitingNo Results AvailableImpaired Glucose Tolerance|Oxidative Stress|Prediabetes|Impaired Fasting GlucoseOther: low glycemic index diet|Other: high glycemic index diet plus placebo|Drug: high glycemic index diet plus N-acetylcysteinehttps://ClinicalTrials.gov/show/NCT01386645
9010690106Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck CarcinomaActive, not recruitingNo Results AvailableSquamous Cell Carcinoma of the Head and NeckDrug: DCA (dichloroacetate)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01386632
9010790107NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)CompletedNo Results AvailableLeukemia, Myeloid, Acute|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Myelodysplastic Syndromes|Lymphoma|Neuroblastoma|RhabdomyosarcomaBiological: CD3-depleted/CD56+ selected natural killer cells collected from apheresis productshttps://ClinicalTrials.gov/show/NCT01386619
9010890108The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)CompletedHas ResultsSecondary HypogonadismDrug: Androxal (enclomiphene citrate)|Drug: Testosteronehttps://ClinicalTrials.gov/show/NCT01386606
9010990109Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or InhibitionCompletedNo Results AvailableMetabolic Detoxication, Phase IDrug: Basel cocktail+(Fluconazole, Ciprofloxacin, Paroxetine)|Drug: "Basel" Cocktail|Drug: Basel cocktail + Rifampicinhttps://ClinicalTrials.gov/show/NCT01386593
9011090110An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.CompletedNo Results AvailableBrain Metastases|Lung Cancer|Breast Cancer|Melanoma|Malignant GliomaDrug: 2B3-101|Drug: Trastuzumab|Drug: 2B3-101 60 mg/m2 every 4 weeks|Drug: 2B3-101 50 mg/m2 every 3 weekshttps://ClinicalTrials.gov/show/NCT01386580
9011190111A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203CompletedNo Results AvailableHypogonadism|Low TestosteroneDrug: Androxal (enclomiphene citrate)|Drug: Testim (topical testosterone)https://ClinicalTrials.gov/show/NCT01386567
9011290112Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsRecruitingNo Results AvailableProteinuria|Idiopathic Membranous NephropathyDrug: Repository Corticotropin Injection|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01386554
9011390113Multiple Ascending Dose Trial of BYK324677 in Healthy VolunteersCompletedNo Results AvailableType 2 Diabetes MellitusDrug: BYK324677https://ClinicalTrials.gov/show/NCT01386541
9011490114Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCompletedNo Results AvailableCongenital Bleeding Disorder|Haemophilia BDrug: NNC-0156-0000-0009https://ClinicalTrials.gov/show/NCT01386528
9011590115The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)CompletedNo Results AvailableGenetic Disease|Communicationhttps://ClinicalTrials.gov/show/NCT01386515
9011690116CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNo Results AvailableBreast Cancer|Colon Cancer|Pancreatic Cancer|Sarcoma|Ovarian CancerBiological: p53: 264-272 peptide|Drug: CT-011https://ClinicalTrials.gov/show/NCT01386502
9011790117Immune Responses to Two Experimental HIV Vaccines in Healthy AdultsCompletedNo Results AvailableHIV Negative|Adaptive Immunity|Innate ImmunityBiological: VRC-HIVDNA016-00-VP|Biological: VRC-HIVADV014-00-VPhttps://ClinicalTrials.gov/show/NCT01386489
9011890118(18F)FCWAY and the Blood-Brain BarrierRecruitingNo Results AvailableDrug Resistancehttps://ClinicalTrials.gov/show/NCT01386476
9011990119AZD6244 in Children With Low-Grade GliomasRecruitingNo Results AvailableOptic Glioma|Pilocytic Astrocytoma|Low Grade Glioma|Fibriullary AstrocytomaDrug: AZD6244https://ClinicalTrials.gov/show/NCT01386450
9012090120Natural History of Individuals With Immune System Problems That Lead to Fungal InfectionsRecruitingNo Results AvailableAPECEDhttps://ClinicalTrials.gov/show/NCT01386437

* Görseller ve İçerik tekif hakkına sahip olabilir